Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
How is 'A Knight of the Seven Kingdoms' connected to 'Game of Thrones'? - 275% of Arab Israelis support Arab party joining government coalition post-war, survey reveals
- 34 Electric Vehicle Brands: Execution, Unwavering quality, and Development
- 4When is MLK Day? Plus, the dates of when other federal holidays land in 2026.
- 5Rio Tinto resumes operations at three Pilbara port terminals after cyclone Narelle
- Israeli media reports Iran attacking greater Tel Aviv region
- Step by step instructions to Pick A Keep money with High Fixed Store Loan costs
- WATCH: IDF strikes, dismantles missile launchers in southern Lebanon
- Sophie Kinsella, 'Confessions of a Shopaholic' author, dies at 55 after battle with cancer
- Somalia set for 'historic' first offshore oil drilling
- Ober Gabelhorn glacier reveals remains of man missing for over three decades
- Israel reports killing another senior Iranian oil official
- Vote In favor of Your Favored Web based Dating Application
- Pleasant Cycle Courses All over the Planet
